Risk factors of metastasis in oral squamous cell carcinomas

Oncology

Volumn 58, Issue 2, 2000, Pages 137-143

  Osaki, Tokio ^a   Kimura, Tsuyoshi ^b   Tatemoto, Yukihiro ^b   Yamamoto, Tetsuya ^b   Yoneda, Kazunori ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Invasion mode of tumor cells; Metastasis; NK activity; Oral carcinoma; p53 and p21 proteins

Indexed keywords

GAG PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL INFILTRATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MOUTH CANCER; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

EID: 0034004971     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012090     Document Type: Article

References (25)

1. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M: Expression of matrix metalloprotcinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 1993;99:18-23.
2. Sehgal G, Hua J. Bernhard EJ, Sehgal I, Thompson TC, Muschel RJ: Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol 1998;152:591-596.
3. Shinohara M, Hiraki A, IkebeT, Nakamura S, Kurahara S, Shirasuna K, Garrod DR: Immunohistochemical study of desmosomes in oral squamous cell carcinoma: Correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 1998;184:369-381.
4. Sulzer MA, Leers MP, van Noord JA, Bollen EC, Theunissen PH: Reduced E-cadherin expression is associated with increase lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med 1998;157:1319-1323.
5. Enomoto A, Kato K, Yagita H, Okumura K: Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice. Cancer Immunol Immunother 1997;44:204-210.
6. Osaki T, Hirota J, Yoneda K, Yamamoto T, Ueta E: Clinical and histopathologic characteristics of tongue and gingiva carcinomas with occult and clinically evident cervical lymphnode metastasis. Int J Oral Maxillofac Surg 1996;25:274-278.
7. Shear M, Hawkins DM, Farr HW: The prediction of lymph node metastases from oral squamous carcinoma. Cancer 1976;37:1901-1907.
8. Nozaki S, Endo Y, Kawashiri S, Nakagawa K, Yamamoto E, Yonemura Y, Sasaki T: Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: Association with mode of invasion and lymph node metastasis. Oral Oncol 1998;34:58-62.
9. Yamamoto E, Miyakawa A. Kohama G: Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 1984;6:938-947.
10. Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Ueta E, Kimura T: Expression of p53 and p21 protein in oral squamous cell carcinoma: Correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract 1998;194:821-830.
11. Jin Y-T, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, EI-Naggar AK: The prognostic significance of the biomarkcrs p21, p53 and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998;82:2159-2165.
12. Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hcmstreet GP, Waldman FM, Chew K, Whceless LL, Faraggi D: Biomarker study of primary nonmetastatic versus mctastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network. Clin Cancer Res 1998;4:1267-1271.
13. Noguchi S, Koyama H, Kasugai T, Tsuji N, Tsuda H, Akiyama F, Motomura K. Inaji H: The possible prognostic significance of p53 immunostaining status of the primary tumor in patients developing local recurrence after breast-conserving surgery. Oncology 1988;55: 450-455.
14. Clarke PJ, Burton RC, Wood KJ: Allogencic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour. Int J Cancer 1993;55:996-1002.
15. Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 1980;65:801-809.
16. UICC: TNM classification of malignant tumours, ed 4. Berlin, Springer, 1987, pp 16-18.
17. Shiba R, Sakoda S. Arima R, Kashima K: Study on T classification in squamous cell carcinomas of the mandibular gingiva. J Jpn Soc Oral Tumor 1994;6:74-77.
18. Furukawa A, Tsuji M, Nishitani M. Kanda K, Inoue Y, Kanayama H, Kagawa S: Role of the matrix metalloprotcinase and tissue inhibitors of metalloprotcinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Urology 1998;51:849-853.
19. Muller D. Wolf C, Abecassis J, Millon R, Engelmann A. Bronner G, Rouyer N. Rio M-C, Eber M, Methlin G, Chambon P, Basset P: Increased stromclysin 3 gene expression is associated with increased local invasive-ness in head and neck squamous cell carcinomas. Cancer Res 1993;53:165-169.
20. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-2451.
21. Yoneda K, Yokoyama T, Yamamoto T, Hatabe T, Osaki T: p53 gene mutations and p21 protein expression induced by TGF-β and γ-rays in squamous cell carcinoma cells - No involvement of p53 in the induction. Eur J Cancer, in press.
22. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-intcracting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
23. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994;9:3389-3396.
24. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G, Higuchi Y, Tsuruo T, Muto T: Role of p5 3 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 1998;41:68-74.
25. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takcuchi S, Yang R, Chen D-L, Vogelstein B, Kocffler HP: Absence of WAFl mutations in a variety of human malignancies. Blood 1994;84:3781-3784.